Please Wait...

Harry Genant

Translation skills

Main profile

Harry K. Genant
Chairman, Emeritus

Harry K. Genant is a co-founder of Synarc and Professor Emeritus of Radiology, Orthopedic Surgery, Medicine, and Epidemiology at the University of California San Francisco. While at UCSF, he founded the Osteoporosis and Arthritis Research Group, which has been widely acclaimed as a leading source of research in noninvasive imaging methods applied to patients with osteoporosis, arthritis, and orthopedics. He is currently a member of the Synarc board of directors and a senior consultant to the company.

Dr. Genant received his medical degree from Northwestern University in Chicago, Illinois, and completed his internship at Johns Hopkins University in Baltimore, Maryland, where he was part of the Osler Medical Service. He completed his residency training in Medicine and in Radiology at the University of Chicago, after which he was Chief of Musculoskeletal Radiology at UCSF for the following 30 years. Dr. Genant founded the Osteoporosis and Arthritis Research Group (OARG) in the Department of Radiology at UCSF in 1986, and remains its Executive Director. The OARG has been widely acclaimed as a leading source of research in noninvasive imaging methods applied to osteoporosis, arthritis and orthopedics.

Dr. Genant has edited or co-edited more than 30 text books, authored or co-authored more than 170 chapters and invited articles, nearly 500 peer-reviewed articles in scientific and medical journals, and over 1000 abstracts presented at national and international scientific and professional gatherings. He is on the editorial boards of Bone, the Journal of Spine Disorders, Osteoporosis International, the Journal of Bone and Mineral Research, and the Journal of Clinical Densitometry, and was recently named Associate Editor of Bone.

Dr. Genant is currently President-Elect of the International Skeletal Society and Chair of the WHO Task Force on Osteoporosis and Chair of the International Steering Committee for Artificial Gravity for the joint US, German and Russian Space Programs. He has served as Chair of the Scientific Committee of the First, Second, and Third International Conferences on Osteoporosis in China, and was co-chair of the Second International Conference on Osteoporosis in Japan. In 1998 he was voted Outstanding Physician of the Year by the International Society for Clinical Densitometry. Dr. Genant was also awarded honorary lifetime memberships in the American Academy of Orthopaedic Surgeons and the International Society for the Study of the Lumbar Spine. He is also an honorary member of the Chinese Osteoporosis Society, the Chilean Society of Osteology, the Hungarian Society of Osteology, and the European Society of Skeletal Radiology. He is also an Honorary Fellow of the Royal College of Radiologists.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Think a #CTMS implementation takes too much time and too many resources? It doesn’t have to. Learn how a configurab… https://t.co/yowxvVTyP3
Bioclinica (2 days ago)
We think you should have access to the full suite of #ClinicalDataManagement services to ensure high-quality, relia… https://t.co/jVuliQwFo3
Bioclinica (2 weeks ago)
A mid-study change to a new #IRT vendor can be required for a number of reasons and can introduce a certain amount… https://t.co/sU7akWjdCD
Bioclinica (2 weeks ago)
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/rlYiFYpR6G
Bioclinica (3 weeks ago)
Rapid #CTMS implementation shouldn’t mean sacrificing features and functionality. With a modular approach, a full-f… https://t.co/gwqFtB8lhe
Bioclinica (4 weeks ago)
How prepared are you for a #clinicaltrial transition? With proper planning, the impact to sites and patients can be… https://t.co/vOqwC5vzzd
Bioclinica (5 weeks ago)